merck q4 - Search News

Weak 2025 Guidance Mangles Merck Stock Today

Hosted on MSN · 1d

Merck Stock Slumps as Q4 Profits, 2025 Forecast Fall Short

Key Takeaways Merck shares fell sharply Tuesday morning after the drugmaker's profits and 2025 outlook fell short of estimates.Revenue and adjusted earnings, however, managed to top expectations.Sales of a few Merck drugs were hit by lower international demand and lower pricing in the U.

Business Insider · 1d

MRK Earnings: Weak 2025 Guidance Mangles Merck Stock Today

Merck (MRK) stock was mangled today after the pharmaceutical and vaccine company released its guidance for 2025. The company expects adjusted

Investor's Business Daily on MSN · 1d

Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance Weigh On Shares

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

Q4 Earnings Snapshot

YAHOO!Finance · 1d

Merck (MRK) Q4 2024 Earnings Call Transcript

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter Dannenbaum,

The Washington Post · 1d

Merck: Q4 Earnings Snapshot

On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.48. Earnings, adjusted for one-time gains and costs, came to $1.72 per share. The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.69 per share.

Business Insider · 1d

Merck & Co Inc. Q4 Earnings Summary

Below are the earnings highlights for Merck & Co Inc. (MRK): Earnings: $3.743 billion in Q4 vs. -$1.226 billion in the same period

7h

Should You Pick MRK Stock At $90?

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

2d

Merck Q4 2024 Earnings Preview: Headwinds ahead, but familiar strengths to persist

Truist Securities expressed confidence in its latest note that Merck will be able to navigate the upcoming Gardasil headwinds ...

1d

Merck reports Q4 adjusted EPS $1.72, consensus $1.67

Reports Q4 revenue $15.6B, consensus $15.51B. “We delivered strong growth in 2024, reflecting demand for our innovative portfolio, including ...

1d

Why Merck Stock Is Plummeting Today

Shares of Merck (NYSE: MRK) were trading lower on Tuesday. The drop comes as the S&P 500 gained 0.5% and the Nasdaq Composite ...

Merck Reports Mixed Q4: Beats Revenue, Short on EPS Expectations

When compared against market expectations, Merck’s fourth-quarter results were a mixed bag. The company reported non-GAAP EPS ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results